Jamaica Broilers Group (JBG) for the three months ended July 31, 2022 reported total revenues of $22.98 billion, a 31% increase on the $17.61 billion reported in 2021. Of total revenues:

• The Jamaica Operations contributed $13.73 billion, a 39% increase compared to $9.90 billion for the same period of 2021.
• US Operations recorded an increase of 46% to total $10.62 billion relative to $7.28 billion last year.
• Haiti Operating contributed $85.63 million, a decline of 80% when compared to $425.71 million.
• Other Caribbean Operations recorded $348.70 million (2021: nil)

Cost of Sales rose by 26% to $17.68 billion from $14.02 billion in 2021. As such, gross profit for the first quarter reflected an increase of 48% to close at $5.31 billion versus $3.59 billion booked for the corresponding period in 2021.

Other income decreased 47% from $150.65 million for the first quarter of 2021 to $79.32 million in 2022. Distribution costs increased 9% to close at $689.81 million relative to $631.17 million recorded for the prior year’s comparable period, while administration and other expenses rose by 25% to $2.98 billion (2021: $2.38 billion).

Operating profit for the period increased by 137%, totalling $1.72 billion relative to $725.09 million last year.

Finance Income amounted to $778,000 (2021: nil).

Finance costs declined by 3% to $319.63 million (2021: $329.97 million).

Profit before taxation increased to $1.40 billion (2021: $395.12 million). Tax charges for the quarter totalled $331.91 million (2021: $119.64 million). As such, net profit amounted to $1.07 billion (2021: $275.48 million).

Total comprehensive income amounted to $919.75 million (2021: $232.29 million). Net profit attributable to shareholders amounted to $1.08 billion (2021: $290.33 million).

Consequently, earnings per share (EPS) totalled $0.90 (2021: EPS $0.24). The trailing twelve months EPS amounted to $3.27. The total shares used in our calculation amounted to 1,199,276,400 units. Notably, JBG closed the trading period on September 8, 2022 at a price of $27.96 with a corresponding P/E of 8.55 times.

Balance Sheet at a glance:

Total assets amounted to $61.87 billion as at July 31, 2022 relative to $52.92 billion a year prior. The increase in total assets was due mainly an increase in ‘Inventories’ and ‘Biological assets’ which rose 32% and 37%, respectively to $16.81 billion (2021: $12.76 billion) and $15.69 billion (2021: $11.48 billion), respectively.

Shareholder’s equity amounted to $22.01 billion (2021: $18.99 billion) with a book value per share of $18.35 (2021: $15.83).

Disclaimer:

Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.